Accentus Medical is pleased to announce the application of its proprietary Agluna® silver ion based antimicrobial surface treatment to in excess of 2,000 custom patient specific orthopaedic devices.
Accentus Medical is pleased to announce the advancement in clinical adoption of its proprietary Acusure Ag® coating on a groundbreaking orthopaedic device enabling external surgical implants to be directly attached into bone.
Accentus Medical is implementing a business continuity plan and remains well prepared to continue to work effectively during the COVID19 pandemic, to assist and support our global customer base during this forthcoming difficult time.iew text as example
Accentus Medical is pleased to announce a funding award from Innovate UK. The project is driven by recent market trend towards more complex device materials, such as 3-D porous structures formed by additive layer manufacturing techniques.
Accentus Medical, a leading developer of advanced surface modifications and coating technologies, is delighted to announce its success in winning the Best New UK Medtech Development Programme in the OBN 2015 Awards.